pharmaphorum| News & views on pharma and biotech’s evolving future

Sales & Marketing

What can FDA really do about DTC pharma advertising?

What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?

Patients

Strengthening safety: The critical role of reliable labellin...

Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.

Digital

The AI drug discovery race: Who’s leading the charge?

News

After internal setbacks, Pfizer buys obesity player Metsera

Pfizer's answer to a string of disappointing projects in obesity R&D? Bolt on a promising pipeline from another developer.

News

Bayer starts pivotal Parkinson's cell therapy trial

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway.

Featured Content

Sales & Marketing

What can FDA really do about DTC pharma advertising?

What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?

Digital

The AI drug discovery race: Who’s leading the charge?

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market

Digital

Frontiers Health limited series podcast - Aline Noizet

FH25: The art of connection at Frontiers Health with Aline N...

Aline Noizet, founder of Digital Health Connector, talks with Deep Dive editor Eloise McLennan about the relationships that make innovation possible.

Digital

The right AI for the right job, with Iya Khalil

In a post-BIO virtual interview, Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and genome sciences at Merck & Co (MSD in Europe).

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Newsletters and Deep Dive
digital magazine

Latest News

News

After internal setbacks, Pfizer buys obesity player Metsera

Pfizer's answer to a string of disappointing projects in obesity R&D? Bolt on a promising pipeline from another developer.

News

Bayer starts pivotal Parkinson's cell therapy trial

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway.

News

Stealth's patience rewarded as FDA approves Barth drug

After a long haul, Stealth BioTherapeutics has finally claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome.

News

FDA clears subcutaneous Keytruda in a boost to MSD

MSD's Keytruda will soon be available as a subcutaneous injection, improving convenience for patients and defending it from a looming patent loss.

Views & Analysis

Sales & Marketing

What can FDA really do about DTC pharma advertising?

What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?

Patients

Strengthening safety: The critical role of reliable labellin...

Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.

R&D

From the White House to AI drug discovery: Dr Rahul Gupta on...

White Papers & Webinar

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market